NEW YORK (GenomeWeb News) – Microfluidic Systems yesterday said that it will use Applied Biosystems’ TaqMan assays in its Bioagent Autonomous Networked Detector for airborne pathogens.
Microfluidic Systems said that ABI will manufacture the assays, which can be used for detecting harmful pathogens. It noted that ABI’s TaqMan assays have provided more than 5.2 million anthrax screening tests through ongoing mail-screening applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.